Skip to main content
Clinical Trials/CTRI/2024/07/070188
CTRI/2024/07/070188Not yet recruitingPhase 3

CLINICO-ANATOMICAL EVALUATION OF EFFECT OF GOGHRITA NASYA AND MARMA CHIKITSA IN ARDHAVABHEDAKA (MIGRAINE)

Post Graduate Institute of Ayurveda and Research DSRRAU Jodhpur1 site in 1 country100 target enrollmentStarted: August 5, 2024Last updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
Improvement in clinical sign and symptoms like intensity of Headache, duration of Headache, frequency of headache and other associated symptoms of Migraine

Study Overview

Brief Summary

The Migraine Research Foundation believes that Migraine is the third most prevalent disease in the world and the sixth most disabled disease in health. In modern science, the treatment comprises of both pharmacotherapy and non pharmacological treatment but these are not acceptable due to their drawbacks. so there arises the need for the approach from Ayurveda to manage and prevent the disease Migraine. A study will be conducted to evaluate the efficacy of Goghrita Nasya and Marma Chikitsa in the management of Ardhavabhedaka (Migraine). The study will involve 100 individuals randomly assigned to two groups: Each group will consist of 50 individuals. Group A (Goghrita Nasya): - Individuals in this group will receive Pratimarsha Nasya of Goghrita, which involves instilling 2-2 drops of Goghrita into each nostril once a day for duration of 2 months. Group B (Marma Chikitsa): - Marma Chikitsa will be administered to the individuals, targeting specific Marma points. Firstly Tila Taila will be applied and than 10-12 times pressure will be given to each Marma point once a day for duration of 2 month.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
16.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.Patients having symptoms of Ardhavabhedaka (Migraine) according to Ayurvedic classics as well as modern science.
  • Patient who willing to take Nasya or Marma Chikitsa.
  • Person who will be ready to sign the consent form.

Exclusion Criteria

  • 1.Patients below the age of 16 years and above the age of 60 years.
  • Chronic migraine and other type of primary headaches.
  • Known cases of secondary headache caused by meningitis, tumour, cervical spondylitis or other neurological causes.
  • 4.Patients with severe systemic disorders as uncontrolled Hypertension, Cardiac Problem, Diabetes Mellitus, Tuberculosis, Leprosy, Paralysis, malignant disease etc.
  • 5.Referred pain in half of head due to disorders of ear, eye, teeth, throat etc.
  • 6.Pregnancy.
  • 7.Use of other alternative medication during Ayurvedic treatment.
  • 8.Any pervious kind of surgical history related to site of these Marma.

Outcomes

Primary Outcomes

Improvement in clinical sign and symptoms like intensity of Headache, duration of Headache, frequency of headache and other associated symptoms of Migraine

Time Frame: 3 months

Secondary Outcomes

  • Improvement in MIDAS score and quality of life(3 months)

Investigators

Sponsor
Post Graduate Institute of Ayurveda and Research DSRRAU Jodhpur
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Deepa

Dr Sarvepalli Radhakrishnan Rajasthan Ayurveda University, Jodhpur

Study Sites (1)

Loading locations...

Similar Trials

Effect of Goghrita Nasya and Marma... | Clinical Trial